Filing Details

Accession Number:
0001127602-12-026039
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-09-10 14:51:30
Reporting Period:
2012-09-06
Filing Date:
2012-09-10
Accepted Time:
2012-09-10 14:51:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1014739 Bioscrip Inc. BIOS Retail-Drug Stores And Proprietary Stores (5912) 050489664
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1199080 Z Myron Holubiak 100 Clearbrook Road
Elmsford NY 10523
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.0001 Par Value Acquisiton 2012-09-06 8,400 $4.28 38,400 No 4 M Direct
Common Stock, $.0001 Par Value Disposition 2012-09-06 8,400 $8.51 30,000 No 4 S Direct
Common Stock, $.0001 Par Value Acquisiton 2012-09-07 1,200 $4.28 31,200 No 4 M Direct
Common Stock, $.0001 Par Value Disposition 2012-09-07 1,200 $8.50 30,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $.0001 Par Value Director Stock Option Disposition 2012-09-06 8,400 $0.00 8,400 $4.28
Common Stock, $.0001 Par Value Director Stock Option Disposition 2012-09-07 1,200 $0.00 1,200 $4.28
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,200 2012-09-20 No 4 M Direct
0 2012-09-20 No 4 M Direct
Footnotes
  1. These sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2012.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $8.50 to $8.54, inclusive. The reporting person undertakes to provide BioScrip, Inc., any security holder of BioScrip, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. Fully Vested.